If the AI Trade Unwinds, What’s Actually the Best Safe Haven?

Cryptocurrency, Precious Metals, Technology

Walmart’s First Nuclear PPA: What It Signals About Corporate Energy’s Future

Consumer Goods, Energy

Everyone’s Selling Tech, Should You Be Buying Microsoft?

Technology

How Much Power Do AI Data Centers Need? Enough for Chevron to Build Microsoft a Dedicated Power Plant

Energy, Technology

Can Zumilokibart Become the Next Megablockbuster? Inside AbbVie’s $10.9 Billion Bet on Apogee

Life Science

Tech Tumbles as SpaceX Leads Selloff — These Two Dividend Kings Offer Calm Amid the Chaos

Consumer Goods, Technology

China Adds MP Materials, USA Rare Earth to Export Blacklist in Tit-for-Tat Move

Mining

Micron’s 260% Rally Faces Earnings Test as AI Memory Boom Enters New Phase

Technology

Grail Missed Its Endpoint, But Investors May Have Missed the Real Story

Life Science

What the SpaceX IPO Teaches Investors About the Coming Anthropic and OpenAI Offerings

Technology

VOO vs. RSP: The Hidden Risk in Buffett’s Go-To S&P 500 ETF That Most Investors Miss

Financial Service, Technology

AI Rewrites Drug Discovery: Eli Lilly and Twist Bioscience Chart Two Distinct Industrialization Paths

Life Science, Technology

Nvidia and Intel Rallied Too Much, Broadcom Is the AI Chip Bargain Investors Need

Technology

Why CRISPR Therapeutics Stock Is Stuck Despite Boasting the World’s First Approved CRISPR Therapy

Life Science

Nebius to Join Nasdaq-100 After 1,320% Rally Fueled by Global AI Compute Crunch

Technology